Our top pick for
Building a portfolio
Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.
Cabot Corporation is a specialty chemicals business based in the US. Cabot Corporation shares (CBT) are listed on the NYSE and all prices are listed in US Dollars. Cabot Corporation employs 4,500 staff and has a trailing 12-month revenue of around 0.00.
|Latest market close||$50.05|
|52-week range||$34.65 - $64.83|
|50-day moving average||$52.54|
|200-day moving average||$55.80|
|Wall St. target price||$71.67|
|Dividend yield||$1.4 (2.79%)|
|Earnings per share (TTM)||$-0.95|
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
|1 week (2021-09-17)||0.34%|
|1 month (2021-08-25)||-7.96%|
|3 months (2021-06-25)||-11.79%|
|6 months (2021-03-25)||-2.46%|
|1 year (2020-09-25)||42.07%|
|2 years (2019-09-25)||10.53%|
|3 years (2018-09-25)||65.46|
|5 years (2016-09-23)||51.37|
Valuing Cabot Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Cabot Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Cabot Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.83. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Cabot Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Cabot Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $596 million.
The EBITDA is a measure of a Cabot Corporation's overall financial performance and is widely used to measure a its profitability.
|Revenue TTM||$3.2 billion|
|Operating margin TTM||13.88%|
|Gross profit TTM||$506 million|
|Return on assets TTM||8.79%|
|Return on equity TTM||-1.4%|
|Market capitalisation||$2.8 billion|
TTM: trailing 12 months
There are currently 1.2 million Cabot Corporation shares held short by investors – that's known as Cabot Corporation's "short interest". This figure is 7.4% up from 1.2 million last month.
There are a few different ways that this level of interest in shorting Cabot Corporation shares can be evaluated.
Cabot Corporation's "short interest ratio" (SIR) is the quantity of Cabot Corporation shares currently shorted divided by the average quantity of Cabot Corporation shares traded daily (recently around 271542.54385965). Cabot Corporation's SIR currently stands at 4.56. In other words for every 100,000 Cabot Corporation shares traded daily on the market, roughly 4560 shares are currently held short.
However Cabot Corporation's short interest can also be evaluated against the total number of Cabot Corporation shares, or, against the total number of tradable Cabot Corporation shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Cabot Corporation's short interest could be expressed as 0.02% of the outstanding shares (for every 100,000 Cabot Corporation shares in existence, roughly 20 shares are currently held short) or 0.022% of the tradable shares (for every 100,000 tradable Cabot Corporation shares, roughly 22 shares are currently held short).
Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Cabot Corporation.
Find out more about how you can short Cabot Corporation stock.
Dividend payout ratio: 30.5% of net profits
Recently Cabot Corporation has paid out, on average, around 30.5% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 2.79% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Cabot Corporation shareholders could enjoy a 2.79% return on their shares, in the form of dividend payments. In Cabot Corporation's case, that would currently equate to about $1.4 per share.
While Cabot Corporation's payout ratio might seem fairly standard, it's worth remembering that Cabot Corporation may be investing much of the rest of its net profits in future growth.
Cabot Corporation's most recent dividend payout was on 9 September 2021. The latest dividend was paid out to all shareholders who bought their shares by 25 August 2021 (the "ex-dividend date").
Cabot Corporation's shares were split on a 2:1 basis on 24 March 1996. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Cabot Corporation shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Cabot Corporation shares which in turn could have impacted Cabot Corporation's share price.
Over the last 12 months, Cabot Corporation's shares have ranged in value from as little as $34.6521 up to $64.8301. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while Cabot Corporation's is 1.6425. This would suggest that Cabot Corporation's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Cabot Corporation operates as a specialty chemicals and performance materials company. It operates through three segments: Reinforcement Materials, Performance Chemicals, and Purification Solutions. The company offers rubber grade carbon blacks used in tires as a rubber reinforcing agent and performance additive, as well as in industrial products, such as hoses, belts, extruded profiles, and molded goods; and engineered elastomer composites. It also provides specialty grades of carbon black used in inks, coatings, plastics, adhesives, toners, batteries, and displays applications; masterbatch and conductive compound products for use in automotive, industrial, packaging, infrastructure, agriculture, consumer products, and electronics industries; inkjet colorants used in the inkjet printing applications; fumed silica used in adhesives, sealants, cosmetics, batteries, inks, toners, silicone elastomers, coatings, polishing slurries, and pharmaceuticals; fumed alumina used in various products, including inkjet media, lighting, coatings, cosmetics, and polishing slurries; and aerogel, a hydrophobic, silica-based particle for use in various thermal insulation and specialty chemical applications. In addition, the company offers activated carbon products used for the purification of water, air, food and beverages, pharmaceuticals, and other liquids and gases; and activated carbon solutions for activated carbon injection in coal-fired utilities, mobile water filter units, and carbon reactivation services. The company sells its products through distributors and sales representatives in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Cabot Corporation was founded in 1882 and is headquartered in Boston, Massachusetts.
Everything we know about the Enfusion IPO, plus information on how to buy in.
Everything we know about the Intuity Medical IPO, plus information on how to buy in.
Everything we know about the Pyxis Oncology IPO, plus information on how to buy in.
Everything we know about the AEON Biopharma IPO, plus information on how to buy in.
Everything we know about the IHS Holding Ltd IPO, plus information on how to buy in.
Everything we know about the BT Brands IPO, plus information on how to buy in.
Everything we know about the Immix IPO, plus information on how to buy in.
Everything we know about the Keter Group SA IPO, plus information on how to buy in.
Everything we know about the Theseus Pharmaceuticals IPO, plus information on how to buy in.
See the 10 biggest gainers on the New York Stock Exchange and Nasdaq on Sep. 20, 2021
finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which finder.com receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. finder.com compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.